Funduscopy:to dilate or not to dilate?

Dilating the pupil with mydriatic eye drops before funduscopy doubles sensitivity for testing for diabetic retinopathy, but what additional risk does dilation carry? Gerald Liew and coauthors assess the evidence

Funduscopy is commonly used by non-ophthalmologists to screen for diabetic retinopathy.^w1 The sensitivity of funduscopy through a dilated pupil for detecting diabetic retinopathy is twice as high as detection through an undilated pupil,^w2 but surveys of general practitioners have found that only one in 250 regularly dilate pupils, even when assessing patients at high risk of diabetic eye disease.^w3 A common reason for not dilating pupils is concern about the risk of precipitating acute angle closure glaucoma.^w3 How big is this risk?

Mydriatic eye drops being applied
SUE-FORD/SPL

Recent population based studies indicate that this risk is extremely low. In the Rotterdam study of 6760 people, routine use of mydriatic eye drops in all participants aged 55 and over precipitated acute angle closure glaucoma in only two individuals (0.03%).^w4 The Baltimore eye survey of 4870 people found no cases of acute glaucoma precipitated by mydriasis.^w5 In Australia, the Blue Mountains eye study of 3654 people also found no cases of acute angle closure glaucoma resulting from routine pupil dilation (PM, unpublished data). Although some cases may have been missed as participants were not monitored until the effects of mydriasis wore off, the authors of all three studies believe this to be extremely unlikely. Participants in all the studies were given clear instructions to contact the investigators or a medical practitioner immediately if symptoms of acute glaucoma developed, and although several notifications of minor eye irritation were received, none were found to be caused by acute angle closure glaucoma, other than the two cases in the Rotterdam study. Cross checking with doctors and ophthalmologists in the study areas also did not find any extra cases of mydriatic induced acute glaucoma in study participants.^w4-w5 A systematic review reported that out of an estimated 600 000 individuals who received mydriatic eye drops, 33 (0.006%) developed acute angle closure glaucoma, giving an estimated risk of one in 20 000.w6 The same review found that in almost 4000 people whose pupils were dilated using tropicamide, none developed acute glaucoma as a result of the dilatation. We are aware of only two cases of tropicamide-induced angle closure glaucoma from the published literature.w7 Thus, these studies place the risk of acute angle closure glaucoma caused by pharmacological pupil dilation at one to six per 20 000 people in the general population.

Even in traditional high risk groups, the risk of precipitating acute glaucoma with mydriatic eye drops has been found to be very low. In 13 studies involving over 1000 people with chronic open angle glaucoma, none developed acute glaucoma after mydriasis (0%).w6 In the Rotterdam study one out of 149 subjects (0.7%) with flat anterior chambers on slit lamp examination developed acute glaucoma after mydriasis,^w4 while in the Baltimore eye survey, all of the 38 subjects determined by an ophthalmologist to have potentially occludable angles were dilated without incident, although 10 had received laser iridotomy before dilatation.^w5 These two studies also found that the predictive value of a history of open angle glaucoma or a flat anterior chamber in predicting acute angle closure glaucoma after mydriasis was extremely low (<1%). The authors of both studies recommend that in a primary care setting, warning patients to seek immediate treatment if symptoms of acute glaucoma develop would be more effective than screening for potentially occludable angles.^w4-w5

Few published data exist on Asian populations, whose risk of angle closure is believed to be higher, but a study of 1232 Chinese Singaporeans, where none developed acute glaucoma after mydriasis, puts the risk in Chinese Asians at less than one in 1000.w8 In another study in 2400 Malay Singaporeans one participant developed acute glaucoma, giving a risk of one in 2400 in Malay Asians.^w9

There are good pathophysiological reasons why mydriasis is unlikely to lead to acute glaucoma. Pupil block, the underlying mechanism in acute angle closure, is believed to occur when the pupil is in the mid-dilated position, rather than a fully dilated position.^w10 In fact, the pupil is in a mid-dilated position in dimly lit environments, which paradoxically suggests that being in a darkened room poses more risk in terms of precipitating acute glaucoma than instilling mydriatic eye drops.

Pupil dilation is important for thorough funduscopy, and the risk of precipitating acute angle closure glaucoma with routine use of mydriatics is close to zero. Tropicamide 0.5% is a safe agent for use in primary care.w6 While patients should certainly be warned to seek medical attention if the symptoms of acute angle closure glaucoma (red painful eye, blurry vision, nausea and vomiting) occur, both the patient and doctor should rest assured that this possibility is extremely slight.

Competing interests: None declared.

This editorial was first published in the BMJ (2006;332:3).

1. Frank RN. Diabetic retinopathy. N Engl J Med 2004;350:48-8.
2. Klein R, Klein BE, NeiderMW, Hubbard LD, Meuer SM, Brothers RJ. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology 1985;92:485-91.
3. Adaamson E, Herman W. Patterns of medical care for diabetics in the San Francisco Bay area. Atlanta: Centers for Disease Control, 1988.
4. Wolfs RC, Grobbee DE, Hofman A, de Jong PT. Risk of acute angle-closure glaucoma after diagnosticmydriasis in nonselected subjects: the Rotterdam Study. Investigative Ophthalmology Visual Sci 1997;38:2683-7.
5. Patel KH, Javitt JC, Tielsch JM, Street DA, Katz J, Quigley HA, et al. Incidence of acute angle-closure glaucoma after pharmacologic mydriasis. Am J Ophthalmology 1995;120:709-17.
6. Pandit RJ, Taylor R. Mydriasis and glaucoma: exploding the myth. A systematic review. Diabetic Med. 2000;17:693-9.
7. Brooks AM, West RH, Gillies WE. The risks of precipitating acute angleclosure glaucoma with the clinical use of mydriatic agents. Med J Aust 1986;145:34-6.
8. Foster PJ, Oen FT, Machin D, Ng TP, Devereux JG, Johnson GJ, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol 2000;118:1105-11.
9. Wong TY, Saw SM, Tan DTH. The Singapore Malay eye study. Am J Ophthalmology 2005;139:S13.
10. Mapstone R. Mechanics of pupil block. Br J Ophthalmology 1968;52:19-25.